Lung Transplantation

  • Andrew Roscoe
Chapter

Abstract

Preoperative assessment of the underlying diagnosis allows for optimal intraoperative ventilation settings. Preoxygenation and a smooth induction are essential to avoid pulmonary hypertensive crises and acute right ventricular failure. Transesophageal echocardiography is an invaluable tool in the diagnosis and management of intraoperative hemodynamic instability. A fluid restriction strategy is adopted to reduce the risk of low pressure pulmonary edema. Adequate postoperative analgesia is imperative to facilitate extubation, satisfactory sputum clearance, and early mobilization.

Keywords

Surfactant Ischemia Osteoporosis Cyclosporin Gelatin 

References

  1. 1.
    Christie JD, Edwards LB, Aurora P, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult lung and heart-lung transplantation report-2009. J Heart Lung Transplant. 2009;28:1031–49.PubMedGoogle Scholar
  2. 2.
    Hardy JD, Webb WR, Dalton Jr ML. Lung homotransplantations in man: report of the initial case. JAMA. 1963;186:1065–74.PubMedGoogle Scholar
  3. 3.
    Toronto Lung Transplantation Group. Experience with single lung transplantation for pulmonary fibrosis. JAMA. 1988;259:2258–62.Google Scholar
  4. 4.
    Cai J. Double- and single-lung transplantation: an analysis of twenty years of OPTN/UNOS registry data. Clin Transpl. 2007:1–8.Google Scholar
  5. 5.
    Hadjiliadis D, Angel LF. Controversies in lung transplantation: are two lungs better than one? Semin Respir Crit Care Med. 2006;27:561–6.PubMedGoogle Scholar
  6. 6.
    Chang AC, Chan KM, Lonigro RJ, et al. Surgical patient outcomes after the increased use of bilateral lung transplantation. J Thorac Cardiovasc Surg. 2007;133:532–40.PubMedGoogle Scholar
  7. 7.
    Liao WC, Hwang SL, Ko WJ, et al. Analysis of heart donation for cardiac transplantation at the National Taiwan university Hospital: fifteen-year cases review. Transplant Proc. 2004;36:2365–8.PubMedGoogle Scholar
  8. 8.
    Misis M, Raxach JG, Molto HP, et al. Bispectral index monitoring for early detection of brain death. Transplant Proc. 2008;40:1279–81.PubMedGoogle Scholar
  9. 9.
    Tatlisumak T, Forss N. Brain death confirmed with CT angiography. Eur J Neurol. 2007;14:42–3.Google Scholar
  10. 10.
    Monteiro LM, Bollen CW, van Huffelen AC, et al. Transcranial Doppler ultrasonography to brain death: a meta-analysis. Intensive Care Med. 2006;32:1937–44.PubMedGoogle Scholar
  11. 11.
    Young GB, Shemie SD, Doig CJ, et al. Brief review: the role of ancillary tests in the neurological determination of death. Can J Anaesth. 2006;53:620–7.PubMedGoogle Scholar
  12. 12.
    Morenski JD, Oro JJ, Tobias JD, et al. Determination of death by neurological criteria. J Intensive Care Med. 2003;18:211–21.PubMedGoogle Scholar
  13. 13.
    Wijdicks EF. The diagnosis of brain death. New Engl J Med. 2001;344:1215–21.PubMedGoogle Scholar
  14. 14.
    Palac RT, Summer G, Laird R, et al. Reversible myocardial dysfunction after traumatic brain injury. Prog Transplant. 2003; 13:42–6.PubMedGoogle Scholar
  15. 15.
    Dujardin DS, McCully RB, Wijdicks EF, et al. Myocardial dysfunction associated with brain death: clinical, echocardiographic, and pathologic features. J Heart Lung Transplant. 2001;20:350–7.PubMedGoogle Scholar
  16. 16.
    Smith M. Physiologic changes during brain stem death – lessons for management of the organ donor. J Heart Lung Transplant. 2004;23:S217–22.PubMedGoogle Scholar
  17. 17.
    Barklin A. Systemic inflammation in the brain-dead organ donor. Acta Anaesthesiol Scand. 2009;53:425–35.PubMedGoogle Scholar
  18. 18.
    Shemie SD, Ross H, Pagliarello J, et al. Organ donor management in Canada: recommendations of the forum on medical management to optimize donor organ potential. CMAJ. 2006;174:S13–32.PubMedGoogle Scholar
  19. 19.
    Mascia L, Mastromauro I, Viberti S, et al. Management to optimize organ procurement in brain dead donors. Minerva Anestesiol. 2009;75:125–33.PubMedGoogle Scholar
  20. 20.
    Angel LF, Levine DJ, Restrepo MI, et al. Impact of a lung transplantation donor-management protocol on lung donation and recipient outcomes. Am J Resp Crit Care Med. 2006;174:710–6.PubMedGoogle Scholar
  21. 21.
    Follette DM, Rudich SM, Babcock WD. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant. 1998;17:423–9.PubMedGoogle Scholar
  22. 22.
    Venkateswaran RV, Patchell VB, Wilson IC, et al. Early donor management increases the retrieval rate of lungs for transplantation. Ann Thorac Surg. 2008;85:278–86.PubMedGoogle Scholar
  23. 23.
    Rosendale JD, Kauffman HM, McBride MA, et al. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation. 2003;75:482–7.PubMedGoogle Scholar
  24. 24.
    Kutsogiannis DJ, Pagliarello G, Doig C, et al. Medical management to optimize donor organ potential: review of the literature. Can J Anaesth. 2006;53:820–30.PubMedGoogle Scholar
  25. 25.
    Winton TL. Lung transplantation: donor selection. Semin Thorac Cardiovasc Surg. 1992;4:79–82.PubMedGoogle Scholar
  26. 26.
    Weill D. Donor criteria in lung transplantation: an issue revisited. Chest. 2002;121:2029–31.PubMedGoogle Scholar
  27. 27.
    Gore SM, Taylor RM, Wallwork J. Availability of transplantable organs from brain stem dead donors in intensive care units. BMJ. 1991;302:149–53.PubMedGoogle Scholar
  28. 28.
    Orens JB, Boehler A, de Perrot M, et al. A review of lung transplant donor acceptability criteria. J Heart Lung Transplant. 2003;22:1183–200.PubMedGoogle Scholar
  29. 29.
    Van Raemdonck D, Neyrinck A, Verleden GM, et al. Lung donor selection and management. Proc Am Thorac Soc. 2009;15:28–38.Google Scholar
  30. 30.
    Bhorade SM, Vigneswaran W, McCabe MA, et al. Liberalization of donor criteria may extend the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant. 2000;19:1199–204.PubMedGoogle Scholar
  31. 31.
    Aigner C, Winkler G, Jaksch P, et al. Extended donor criteria for lung transplantation – a clinical reality. Eur J Cardiothorac Surg. 2005;27:757–61.PubMedGoogle Scholar
  32. 32.
    Fischer S, Gohrbandt B, Struckmeier P, et al. Lung transplantation with lungs from donors fifty years of age and older. J Thorac Cardiovasc Surg. 2005;129:919–25.PubMedGoogle Scholar
  33. 33.
    Whiting D, Banerji A, Ross D, et al. Liberalization of donor criteria in lung transplantation. Am Surg. 2003;69:909–12.PubMedGoogle Scholar
  34. 34.
    Kawut SM, Reyentovich A, Wilt JS, et al. Outcomes of extended donor lung recipients after lung transplantation. Transplantation. 2005;79:310–6.PubMedGoogle Scholar
  35. 35.
    Botha P, Trivedi D, Weir CJ. Extended donor criteria in lung transplantation: impact on organ allocation. J Thorac Cardiovasc Surg. 2006;131:1154–60.PubMedGoogle Scholar
  36. 36.
    Wierup P, Harraldsson A, Nilsson F, et al. Ex vivo evaluation of nonacceptable donor lungs. Ann Thorac Surg. 2006;81:460–6.PubMedGoogle Scholar
  37. 37.
    Steen S, Ingemansson R, Eriksson L, et al. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg. 2007;83:2191–4.PubMedGoogle Scholar
  38. 38.
    Cypel M, Yeung JC, Hirayama S, et al. Technique for prolonged normothermic ex vivo lung reperfusion. J Heart Lung Transplant. 2008;27:1319–25.PubMedGoogle Scholar
  39. 39.
    Ingemansson R, Eyjolfsson A, Mared L, et al. Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo. Ann Thorac Surg. 2009;87:255–60.PubMedGoogle Scholar
  40. 40.
    Van Raemdonck D, Rega FR, Neyrinck A, et al. Non-heart-beating donors. Semin Thorac Cardiovasc Surg. 2004;16:309–21.PubMedGoogle Scholar
  41. 41.
    Oto T, Levvey B, McEgan R, et al. A practical approach to clinical lung transplantation from a Maastricht Category III donor with cardiac death. J Heart Lung Transplant. 2007;26:196–9.PubMedGoogle Scholar
  42. 42.
    Snell GI, Oto T, Levvey B, et al. Evaluation of techniques for lung transplantation following donation after cardiac death. Ann Thorac Surg. 2006;81:2014–9.PubMedGoogle Scholar
  43. 43.
    Egan TM. Non-heart-beating donors in thoracic transplantation. J Heart Lung Transplant. 2004;23:3–10.PubMedGoogle Scholar
  44. 44.
    Neyrinck AP, Van De Wauwer C, Geudens N, et al. Comparative study of donor lung injury in heart-beating versus non-heart-beating donors. Eur J Cardiothorac Surg. 2006;30:628–36.PubMedGoogle Scholar
  45. 45.
    De Vleeschauwer S, Van Raemdonck D, Vanaudenaerde B, et al. Early outcome after lung transplantation from non-heart-beating donors is comparable to heart-beating donors. J Heart Lung Transplant. 2009;28:380–7.PubMedGoogle Scholar
  46. 46.
    Aziz TM, Pillay TM, Corris PA, et al. Perfadex for clinical lung procurement: is it an advance? Ann Thorac Surg. 2003;75:990–5.PubMedGoogle Scholar
  47. 47.
    Oto T, Griffiths AP, Rosenfeldt F, et al. Early outcomes comparing Perfadex, Euro-Collins and Papworth solutions in lung transplantation. Ann Thorac Surg. 2006;82:1842–8.PubMedGoogle Scholar
  48. 48.
    Ganesh JS, Rogers CA, Banner NR, et al. Does the method of lung preservation influence outcome after transplantation? An analysis of 681 consecutive procedures. J Thorac Cardiovasc Surg. 2007;134:1313–21.PubMedGoogle Scholar
  49. 49.
    Chen CZ, Gallagher RC, Ardery P, et al. Retrograde flush and cold storage for twenty-two to twenty-five hours lung preservation with and without prostaglandin E1. J Heart Lung Transplant. 1997;16:658–66.PubMedGoogle Scholar
  50. 50.
    Struber M, Fischer S, Niedermeyer J, et al. Effects of exogenous surfactant instillation in clinical lung transplantation: a prospective, randomized trial. J Thorac Cardiovasc Surg. 2007;133:1620–5.PubMedGoogle Scholar
  51. 51.
    Haniuda M, Hasegawa S, Shiraishi T, et al. Effects of inflation volume during lung preservation on pulmonary capillary permeability. J Thorac Cardiovasc Surg. 1996;112:85–93.PubMedGoogle Scholar
  52. 52.
    Sundaresan S, Trachiotis GD, Aoe M, et al. Donor lung procurement: assessment and operative technique. Ann Thorac Surg. 1993;56:1409–13.PubMedGoogle Scholar
  53. 53.
    Maurer JR, Frost AE, Estenne M, et al. International guidelines for the selection of lung transplant candidates. Transplantation. 1998;66:951–6.PubMedGoogle Scholar
  54. 54.
    Oren JB, Estenne M, Arcasoy S, et al. International guidelines for the selection of lung transplant candidates: 2006 update – a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2006;25:745–55.Google Scholar
  55. 55.
    Kanasky Jr WF, Anton SD, Rodrigue JR, et al. Impact of body weight on long-term survival after lung transplantation. Chest. 2002;121:401–6.PubMedGoogle Scholar
  56. 56.
    Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. New Engl J Med. 2004;350:1005–12.PubMedGoogle Scholar
  57. 57.
    Tutic M, Lardinois D, Imfeld S, et al. Lung-volume reduction surgery as an alternative or bridging procedure to lung transplantation. Ann Thorac Surg. 2006;82:208–13.PubMedGoogle Scholar
  58. 58.
    De Soyza A, McDowell A, Archer L, et al. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet. 2001;358:1780–1.PubMedGoogle Scholar
  59. 59.
    Levine SM. A survey of clinical practice of lung transplantation in North America. Chest. 2004;125:1224–38.PubMedGoogle Scholar
  60. 60.
    Egan TM, Murray S, Bustami RT, et al. Development of the lung allocation system in the United States. Am J Transplant. 2006;6:1212–27.PubMedGoogle Scholar
  61. 61.
    Iribarne A, Russo MJ, Davies RR, et al. Despite decreased wait-list times for lung transplantation, lung allocation scores continue to increase. Chest. 2009;135:923–8.PubMedGoogle Scholar
  62. 62.
    Jackson A, Cropper J, Pye R, et al. Use of extracorporeal membrane oxygenation as a bridge to primary lung transplant: 3 consecutive, successful cases and a review of the literature. J Heart Lung Transplant. 2008;27:348–52.PubMedGoogle Scholar
  63. 63.
    Santambrogio L, Nosotti M, Palleschi A, et al. Use of venovenous extracorporeal membrane oxygenation as a bridge to urgent lung transplantation in a case of acute respiratory failure. Transplant Proc. 2009;41:1345–6.PubMedGoogle Scholar
  64. 64.
    Fischer S, Simon AR, Welte T, et al. Bridge to lung transplantation with the novel pumpless interventional lung assist device NovaLung. J Thorac Cardiovasc Surg. 2006;131:719–23.PubMedGoogle Scholar
  65. 65.
    Myles PS. Aspects of anesthesia for lung transplantation. Semin Cardiothorac Vasc Anesth. 1998;2:140–54.Google Scholar
  66. 66.
    Thaik CM, Semigran MJ, Ginns L, et al. Evaluation of ischemic heart disease in potential lung transplant recipients. J Heart Lung Transplant. 1995;14:257–66.PubMedGoogle Scholar
  67. 67.
    Leibowitz DW, Caputo AL, Shapiro GC, et al. Coronary angiography in smokers undergoing evaluation for lung transplantation: is routine use justified? J Heart Lung Transplant. 1994;13:701–3.PubMedGoogle Scholar
  68. 68.
    Vizza CD, Lynch JP, Ochoa LL, et al. Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest. 1998;113:576–83.PubMedGoogle Scholar
  69. 69.
    Choong CK, Meyers BF, Guthrie TJ, et al. Does the presence of preoperative mild or moderate coronary artery disease affect the outcomes of lung transplantation? Ann Thorac Surg. 2006;82:1038–42.PubMedGoogle Scholar
  70. 70.
    Singh H, Bossard RF. Perioperative anaesthetic considerations for patients undergoing lung transplantation. Can J Anaesth. 1997;44:284–99.PubMedGoogle Scholar
  71. 71.
    Ben-Dor I, Kramer MR, Raccah A, et al. Echocardiography versus right-sided heart catheterization among lung transplantation candidates. Ann Thorac Surg. 2006;81:1056–60.PubMedGoogle Scholar
  72. 72.
    Quinlan JJ, Firestone S, Firestone LL. Anesthesia for heart, lung and heart-lung transplantation. In: Kaplan JA, Konstadt SN, Reich DL, editors. Cardiac anesthesia. 4th ed. Philadelphia, PA: WB Saunders; 1999. p. 991–1013.Google Scholar
  73. 73.
    Su NY, Huang CJ, Tsai P, et al. Cardiac output measurement during cardiac surgery: esophageal Doppler versus pulmonary artery catheter. Acta Anaesthesiol Sin. 2002;40:127–33.PubMedGoogle Scholar
  74. 74.
    Cannesson M, Attof Y, Rosamel P, et al. Comparison of FloTrac cardiac output monitoring system in patients undergoing coronary artery bypass grafting with pulmonary artery cardiac output measurements. Eur J Anaesthesiol. 2007;24:832–9.PubMedGoogle Scholar
  75. 75.
    Bein B, Worthmann F, Tonner PH, et al. Comparison of esophageal Doppler, pulse contour analysis, and real-time pulmonary artery thermodilution for the continuous measurement of cardiac output. J Cardiothorac Vasc Anesth. 2004;18:185–9.PubMedGoogle Scholar
  76. 76.
    Funk DJ, Moretti EW, Gan TJ. Minimally invasive cardiac output monitoring in the perioperative setting. Anesth Analg. 2009;108:887–97.PubMedGoogle Scholar
  77. 77.
    Perilli V, Avolio AW, Sacco T, et al. Use of an esophageal echo-Doppler device during liver transplantation: preliminary report. Transplant Proc. 2009;41:198–200.PubMedGoogle Scholar
  78. 78.
    Thys DM, Cohen E, Eisenkraft JB. Mixed venous oxygen saturation during thoracic anesthesia. Anesthesiology. 1988;69:1005–9.PubMedGoogle Scholar
  79. 79.
    Vedrinne C, Bastien O, De Varax R, et al. Predictive factors for usefulness of fiberoptic pulmonary artery catheter for continuous oxygen saturation in mixed venous blood monitoring in cardiac surgery. Anesth Analg. 1997;85:2–10.PubMedGoogle Scholar
  80. 80.
    Jenstrup M, Ejlersen E, Rasmussen LS, et al. Mixed venous oxygen saturation and thoracic electrical impedance for fluid volume management during liver transplantation. Transplant Proc. 1994;26:1793.PubMedGoogle Scholar
  81. 81.
    Venkatesh B, Clutton Brock TH, Hendry SP. A multiparameter sensor for continuous intra-arterial blood gas monitoring: a prospective evaluation. Crit Care Med. 1994;22:588–94.PubMedGoogle Scholar
  82. 82.
    Venkatesh B, Clutton Brock TH, Hendry SP. Evaluation of the Paratrend 7 intravascular blood gas monitor during cardiac surgery: comparison with the C4000 in-line blood gas monitor during cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1995;9:412–9.PubMedGoogle Scholar
  83. 83.
    Venkatesh B. Continuous intra-arterial blood gas monitoring. Crit Care Resusc. 1999;1:140–50.Google Scholar
  84. 84.
    Murkin JM, Adams SJ, Novick RJ, et al. Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study. Anesth Analg. 2007;104:51–8.PubMedGoogle Scholar
  85. 85.
    Myles PS, Leslie K, McNeil J, et al. Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomised controlled trial. Lancet. 2004;363:1757–63.PubMedGoogle Scholar
  86. 86.
    Puri GD, Murthy SS. Bispectral index monitoring in patients undergoing cardiac surgery under cardiopulmonary bypass. Eur J Anaesthesiol. 2003;20:451–6.PubMedGoogle Scholar
  87. 87.
    Liu N, Chazot T, Genty A, et al. Titration of propofol for anesthetic induction and maintenance guided by the bispectral index: closed-loop versus manual control: a prospective, randomized, multicenter study. Anesthesiology. 2006;104:686–95.PubMedGoogle Scholar
  88. 88.
    De Smet T, Struys MM, Neckebroek MM, et al. The accuracy and clinical feasibility of a new bayesian-based closed-loop control system for propofol administration using the bispectral index as a controlled variable. Anesth Analg. 2008;107:1200–10.PubMedGoogle Scholar
  89. 89.
    NICE clinical guideline 65: inadvertent perioperative hypothermia. http://www.nice.org.uk/CG065. Accessed 30 November 2009.
  90. 90.
    Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med. 1996;334:1209–15.PubMedGoogle Scholar
  91. 91.
    Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation. 2003;108:1146–62.PubMedGoogle Scholar
  92. 92.
    Della Rocca G, Brondani A, Costa MG. Intraoperative hemodynamic monitoring during organ transplantation: what is new? Curr Opin Organ Transplant. 2009;14:291–6.PubMedGoogle Scholar
  93. 93.
    Haddad F, Couture P, Tousignant C, et al. The right ventricle in cardiac surgery, a perioperative perspective: anatomy, physiology, and assessment. Anesth Analg. 2009;108:407–21.PubMedGoogle Scholar
  94. 94.
    Pedoto A, Amar D. Right heart function in thoracic surgery: role of echocardiography. Curr Opin Anaesthesiol. 2009;22:44–9.PubMedGoogle Scholar
  95. 95.
    Katz WE, Gasior TA, Quinlan JJ, et al. Immediate effects of lung transplantation on right ventricular morphology and function in patients with variable degrees of pulmonary hypertension. J Am Coll Cardiol. 1996;27:384–91.PubMedGoogle Scholar
  96. 96.
    Michel-Cherqui M, Brusset A, Liu N, et al. Intraoperative transesophageal echocardiographic assessment of vascular anastomoses in lung transplantation: a report on 18 cases. Chest. 1997;111:1229–35.PubMedGoogle Scholar
  97. 97.
    Leibowitz DW, Smith CR, Michler RE, et al. Incidence of pulmonary vein complications after lung transplantation: a prospective transesophageal echocardiographic study. J Am Coll Cardiol. 1994;24:671–5.PubMedGoogle Scholar
  98. 98.
    Huang YC, Cheng YJ, Lin YH, et al. Graft failure caused by pulmonary venous obstruction diagnosed by intraoperative transesophageal echocardiography during lung transplantation. Anesth Analg. 2000;91:558–60.PubMedGoogle Scholar
  99. 99.
    Sukernik MR, Mets B, Bennett-Guerrero E. Patent foramen ovale and its significance in the perioperative period. Anesth Analg. 2001;93:1137–46.PubMedGoogle Scholar
  100. 100.
    Myles PS, Weeks AM, Buckland MR, et al. Anesthesia for bilateral sequential lung transplantation: experience of 64 cases. J Cardiothorac Vasc Anesth. 1997;11:177–83.PubMedGoogle Scholar
  101. 101.
    Hohn L, Schweizer A, Morel DR, et al. Circulatory failure after anesthesia induction in a patient with severe primary pulmonary hypertension. Anesthesiology. 1999;91:1943–5.PubMedGoogle Scholar
  102. 102.
    Myles PS, Weeks AM. Alpha 1-antitrypsin deficiency: circulatory arrest following induction of anaesthesia. Anaesth Intensive Care. 1992;20:358–62.PubMedGoogle Scholar
  103. 103.
    Manthous CA. Avoiding circulatory complications during endotracheal intubation and initiation of positive pressure ventilation. J Emerg Med. 2009;38(5):622–31.PubMedGoogle Scholar
  104. 104.
    Quinlan JJ, Buffington CW. Deliberate hypoventilation in a patient with air trapping during lung transplantation. Anesthesiology. 1993;78:1177–81.PubMedGoogle Scholar
  105. 105.
    Myles PS, Ryder IG, Weeks AM, et al. Diagnosis and management of dynamic hyperinflation during lung transplantation. J Cardiothorac Vasc Anesth. 1997;11:100–4.PubMedGoogle Scholar
  106. 106.
    Myles PS. Pulmonary transplantation. In: Kaplan JA, Slinger PD, editors. Thoracic anesthesia. 3rd ed. Philadelphia, PA: Churchill Livingstone. 2003;295–314.Google Scholar
  107. 107.
    Feltracco P, Serra E, Barbieri F, et al. Anesthetic considerations in lung transplantation for severe pulmonary hypertension. Transplant Proc. 2007;39:1976–80.PubMedGoogle Scholar
  108. 108.
    Snell GI, Salamonsen RF, Bergin P, et al. Inhaled nitric oxide as a bridge to heart-lung transplantation in a patient with end-stage pulmonary hypertension. Am J Resp Crit Care Med. 1995;151:1263–6.PubMedGoogle Scholar
  109. 109.
    de Boer WJ, Waterbolk TW, Brugemann J, et al. Extracorporeal membrane oxygenation before induction of anesthesia in critically ill thoracic transplant patients. Ann Thorac Surg. 2001;72:1407–8.PubMedGoogle Scholar
  110. 110.
    Scheller MS, Kriett JM, Smith CM, et al. Airway management during anesthesia for double-lung transplantation using a single-lumen endotracheal tube with an enclosed bronchial blocker. J Cardiovasc Thorac Anesth. 1992;6:204–7.Google Scholar
  111. 111.
    Abe K, Shimizu T, Takashina M, et al. The effects of propofol, isoflurane and sevoflurane on oxygenation and shunt fraction during one-lung ventilation. Anesth Analg. 1998;87:1164–9.PubMedGoogle Scholar
  112. 112.
    Beck DH, Doepfmer UR, Sinemus C, et al. Effects of sevoflurane and propofol on pulmonary shunt fraction during one-lung ventilation for thoracic surgery. Br J Anaesth. 2001;86:38–43.PubMedGoogle Scholar
  113. 113.
    Pruszkowski O, Dalibon N, Moutafis M, et al. Effects of propofol vs sevoflurane on arterial oxygenation during one-lung ventilation. Br J Anaesth. 2007;98:539–44.PubMedGoogle Scholar
  114. 114.
    Schulte-Sasse U, Hess W, Tarnow J. Pulmonary vascular responses to nitrous oxide in patients with normal and high pulmonary vascular resistance. Anesthesiology. 1982;57:9–13.PubMedGoogle Scholar
  115. 115.
    Macchiarini P, Ladurie F, Cerrina J, et al. Clamshell or sternotomy for double-lung or heart-lung transplantation? Eur J Cardiothorac Surg. 1999;15:333–9.PubMedGoogle Scholar
  116. 116.
    Taghavi S, Birsan T, Pereszlenyi A, et al. Bilateral lung transplantation via two sequential anterolateral thoracotomies. Eur J Cardiothorac Surg. 1999;15:658–62.PubMedGoogle Scholar
  117. 117.
    Tugrul M, Camci E, Karadeniz H, et al. Comparison of volume controlled with pressure controlled ventilation during one-lung anaesthesia. Br J Anaesth. 1997;79:306–10.PubMedGoogle Scholar
  118. 118.
    Unzueta MC, Casas JI, Moral MV. Pressure-controlled versus volume-controlled ventilation during one-lung ventilation for thoracic surgery. Anesth Analg. 2007;104:1029–33.PubMedGoogle Scholar
  119. 119.
    Triantafillou AN, Pasque MK, Huddleston CB, et al. Predictors, frequency and indications for cardiopulmonary bypass during lung transplantation in adults. Ann Thorac Surg. 1994;57:1248–51.PubMedGoogle Scholar
  120. 120.
    Bittner HB, Binner C, Lehmann S, et al. Replacing cardiopulmonary bypass with extracorporeal membrane oxygenation in lung transplantation operations. Eur J Cardiothorac Surg. 2007;31:462–7.PubMedGoogle Scholar
  121. 121.
    de Hoyos A, Demajo W, Snell G, et al. Preoperative prediction for the use of cardiopulmonary bypass in lung transplantation. J Thorac Cardiovasc Surg. 1993;106:787–95.PubMedGoogle Scholar
  122. 122.
    Rocca GD, Passariello M, Coccia C, et al. Inhaled nitric oxide administration during one-lung ventilation in patients undergoing thoracic surgery. J Cardiovasc Thorac Anesth. 2001;15:218–23.Google Scholar
  123. 123.
    Fierobe L, Brunet F, Dhainaut JF, et al. Effect of inhaled nitric oxide on right ventricular function in adult respiratory distress syndrome. Am J Resp Crit Care Med. 1995;15:1414–9.Google Scholar
  124. 124.
    Krasuski RA, Warner JJ, Wang A, et al. Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology. J Am Coll Cardiol. 2000;36:2204–11.PubMedGoogle Scholar
  125. 125.
    Winterhalter M, Simon A, Fischer S, et al. Comparison of inhaled iloprost and nitric oxide in patients with pulmonary hypertension during weaning from cardiopulmonary bypass in cardiac surgery: a prospective randomized trial. J Cardiothorac Vasc Anesth. 2008;22:406–13.PubMedGoogle Scholar
  126. 126.
    Forrest P. Anaesthesia and right ventricular failure. Anaesth Intensive Care. 2009;37:370–85.PubMedGoogle Scholar
  127. 127.
    Martin C, Perrin G, Saux P, et al. Effects of norepinephrine on right ventricular function in septic shock patients. Intensive Care Med. 1994;20:444–7.PubMedGoogle Scholar
  128. 128.
    Kerbaul F, Gariboldi V, Giorgi R, et al. Effects of levosimendan on acute pulmonary embolism-induced right ventricular failure. Crit Care Med. 2007;35:1948–54.PubMedGoogle Scholar
  129. 129.
    Marczin N, Royston D, Yacoub M. Pro: lung transplantation should be routinely performed with cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2000;14:739–45.PubMedGoogle Scholar
  130. 130.
    Gammie JS, Cheul Lee J, Pham SM, et al. Cardiopulmonary bypass is associated with early allograft dysfunction but not death after double-lung transplantation. J Thorac Cardiovasc Surg. 1998;115:990–7.PubMedGoogle Scholar
  131. 131.
    McRae K. Con: lung transplantation should not be routinely performed with cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2000;14:746–50.PubMedGoogle Scholar
  132. 132.
    Aeba R, Griffith BP, Kormos RL, et al. Effect of cardiopulmonary bypass on early graft dysfunction in clinical lung transplantation. Ann Thorac Surg. 1994;57:715–22.PubMedGoogle Scholar
  133. 133.
    Dalibon N, Geffroy A, Moutafis M, et al. Use of cardiopulmonary bypass for lung transplantation: a 10-year experience. J Cardiothorac Vasc Anesth. 2006;20:668–72.PubMedGoogle Scholar
  134. 134.
    Ferrer J, Rodriguez E, Roman A, et al. Factors related to postoperative mortality in lung transplantation for emphysema. Transplant Proc. 2007;39:3317–22.PubMedGoogle Scholar
  135. 135.
    Ko WJ, Chen YS, Lee YC. Replacing cardiopulmonary bypass with extracorporeal membrane oxygenation in lung transplant operations. Artif Organs. 2001;25:607–12.PubMedGoogle Scholar
  136. 136.
    Slinger PD. Perioperative fluid management for thoracic surgery: the puzzle of post-pneumonectomy pulmonary edema. J Cardiothorac Vasc Anesth. 1995;9:442–51.PubMedGoogle Scholar
  137. 137.
    McIlroy DR, Pilcher DV, Snell GI. Does anaesthetic management affect early outcomes after lung transplant? An exploratory analysis. Br J Anaesth. 2009;102:506–14.PubMedGoogle Scholar
  138. 138.
    Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340:409–17.PubMedGoogle Scholar
  139. 139.
    Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA. 2002;25:1499–507.Google Scholar
  140. 140.
    Cicciarelli J. UNOS registry data: effect of transfusions. Clin Transpl. 1990;407–16.Google Scholar
  141. 141.
    Weightman WM, Gibbs NM, Sheminant MR, et al. Moderate exposure to allogeneic blood products is not associated with reduced long-term survival after surgery for coronary artery disease. Anesthesiology. 2009;111:327–33.PubMedGoogle Scholar
  142. 142.
    Fergusson DA, Hebert PC, Mazer CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008;358:2319–31.PubMedGoogle Scholar
  143. 143.
    Kesten S, de Hoyas A, Chaparro C, et al. Aprotinin reduces blood loss in lung transplant recipients. Ann Thorac Surg. 1995;59:877–9.PubMedGoogle Scholar
  144. 144.
    Balsara KR, Morozowich ST, Lin SS, et al. Aprotinin’s effect on blood product transfusion in off-pump bilateral lung transplantation. Interact Cardiovasc Thorac Surg. 2009;8:45–8.PubMedGoogle Scholar
  145. 145.
    McRae K. Pulmonary transplantation. Curr Opin Anaesthesiol. 2000;13:53–9.PubMedGoogle Scholar
  146. 146.
    de Perrot M, Imai Y, Volgyesi GA, et al. Effect of ventilator-induced lung injury on the development of reperfusion injury in a rat lung transplant model. J Thorac Cardiovasc Surg. 2002;124:1137–44.PubMedGoogle Scholar
  147. 147.
    Christie JD, Carby M, Bag R, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2005;24:1454–9.PubMedGoogle Scholar
  148. 148.
    Cottini SR, Lerch N, de Perrot M, et al. Risk factors for reperfusion injury after lung transplantation. Intensive Care Med. 2006;32:557–63.PubMedGoogle Scholar
  149. 149.
    Macdonald P, Mundy J, Rogers P, et al. Successful treatment of life-threatening acute reperfusion injury after lung transplantation with inhaled nitric oxide. J Thorac Cardiovasc Surg. 1995;110:861–3.PubMedGoogle Scholar
  150. 150.
    Della Rocca G, Pierconti F, Costa MG, et al. Severe reperfusion lung injury after double lung transplantation. Crit Care. 2002;6:240–4.PubMedGoogle Scholar
  151. 151.
    Kemming GI, Merkel MJ, Schallerer A, et al. Inhaled nitric oxide for the treatment of early allograft failure after lung transplantation. Munich Lung Transplant Group. Intensive Care Med. 1998;24:1173–80.PubMedGoogle Scholar
  152. 152.
    Meade MO, Granton JT, Matte-Martyn A, et al. A randomized trial of inhaled nitric oxide to prevent ischemia-reperfusion injury after lung transplantation. Am J Resp Crit Care Med. 2003;167:1483–9.PubMedGoogle Scholar
  153. 153.
    Botha P, Jeyakanthan M, Rao JN, et al. Inhaled nitric oxide for modulation of ischemia-reperfusion injury in lung transplantation. J Heart Lung Transplant. 2007;26:1199–205.PubMedGoogle Scholar
  154. 154.
    Bittner HB, Richter M, Kuntze T, et al. Aprotinin decreases reperfusion injury and allograft dysfunction in clinical lung transplantation. Eur J Cardiothorac Surg. 2006;29:210–5.PubMedGoogle Scholar
  155. 155.
    Hsu HH, Ko WJ, Chen JS, et al. Extracorporeal membrane oxygenation in pulmonary crisis and primary graft dysfunction. J Heart Lung Transplant. 2008;27:233–7.PubMedGoogle Scholar
  156. 156.
    Khan NU, Al-Aloul M, Shah R, et al. Early experience with the Levitronix Centrimag device for extra-corporeal membrane oxygenation following lung transplantation. Eur J Cardiothorac Surg. 2008;34:1262–4.PubMedGoogle Scholar
  157. 157.
    Bell R, Dahl JB, Moore RA, et al. Perioperative ketamine for acute postoperative pain. Cochrane Database Syst Rev. 2006;25:CD004603.Google Scholar
  158. 158.
    Altman RD, Perez GO, Sfakianakis GN. Interaction of cyclosporine A and nonsteroidal anti-inflammatory drugs on renal function in patients with rheumatoid arthritis. Am J Med. 1992;93:396–402.PubMedGoogle Scholar
  159. 159.
    Hansen LN, Ravn JB, Yndgaard S. Early extubation after ­single-lung transplantation: analysis of the first 106 cases. J Cardiothorac Vasc Anesth. 2003;17:36–9.PubMedGoogle Scholar
  160. 160.
    Rocca GD, Coccia C, Costa GM, et al. Is very early extubation after lung transplantation feasible? J Cardiothorac Vasc Anesth. 2003;17:29–35.PubMedGoogle Scholar
  161. 161.
    The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301–8.Google Scholar
  162. 162.
    Mitchell JB, Shaw AD, Donald S, et al. Differential lung ­ventilation after single-lung transplantation for emphysema. J Cardiothorac Vasc Anesth. 2002;16:459–62.PubMedGoogle Scholar
  163. 163.
    Waller EA, Aduen JF, Kramer DJ, et al. Safety of percutaneous dilatational tracheostomy with direct bronchoscopic guidance for solid organ allograft recipients. Mayo Clin Proc. 2007;82(12):1502–8.PubMedGoogle Scholar
  164. 164.
    Kermeen FD, McNeil KD, Fraser JF, et al. Resolution of severe ischemia-reperfusion injury post-lung transplantation after administration of endobronchial surfactant. J Heart Lung Transplant. 2007;26:850–6.PubMedGoogle Scholar
  165. 165.
    Samano MN, Minamoto H, Junqueira JJ, et al. Bronchial complications following lung transplantation. Transplant Proc. 2009;41:921–6.PubMedGoogle Scholar
  166. 166.
    Najafizadeh K, Daneshvar A, Dezfouli AA, et al. Pulmonary artery stenosis shortly after lung transplantation: successful balloon dilation and stent insertion in one case. Ann Transplant. 2009;14:52–5.PubMedGoogle Scholar
  167. 167.
    Husain S, Chan KM, Palmer SM, et al. Bacteremia in lung transplant recipients in the current era. Am J Transplant. 2006;6: 3000–7.PubMedGoogle Scholar
  168. 168.
    Bonvillain RW, Valentine VG, Lombard G, et al. Post-operative infections in cystic fibrosis and non-cystic fibrosis patients after lung transplantation. J Heart Lung Transplant. 2007;26: 890–7.PubMedGoogle Scholar
  169. 169.
    Campos S, Caramori M, Teixeira R, et al. Bacterial and fungal pneumonias after lung transplantation. Transplant Proc. 2008;40:822–4.PubMedGoogle Scholar
  170. 170.
    Mason DP, Marsh DH, Alster JM, et al. Atrial fibrillation after lung transplantation: timing, risk factors and treatment. Ann Thorac Surg. 2007;84:1878–84.PubMedGoogle Scholar
  171. 171.
    Barraclough K, Menahem SA, Bailey M, et al. Predictors of decline in renal function after lung transplantation. J Heart Lung Transplant. 2006;25:1431–5.PubMedGoogle Scholar
  172. 172.
    Kahan ES, Petersen G, Gaughan JP, et al. High incidence of venous thromboembolic events in lung transplant recipients. J Heart Lung Transplant. 2007;26:339–44.PubMedGoogle Scholar
  173. 173.
    Bravo C, Gispert P, Borro JM, et al. Prevalence and management of gastrointestinal complications in lung transplant patients: MITOS study group. Transplant Proc. 2007;39:2409–12.PubMedGoogle Scholar
  174. 174.
    Hachem RR, Edwards LB, Yusen RD, et al. The impact of induction on survival after lung transplantation: an analysis of the International Society of Heart Lung Transplantation Registry. Clin Transplant. 2008;22:603–8.PubMedGoogle Scholar
  175. 175.
    Roithmaier S, Haydon AM, Loi S, et al. Incidence of malignancies in heart and/or lung transplant recipients: a single-institution experience. J Heart Lung Transplant. 2007;26:845–9.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Andrew Roscoe
    • 1
  1. 1.Department of AnesthesiaToronto General HospitalTorontoCanada

Personalised recommendations